Pharmaceuticals announced that a new patent has been granted by the Indian Patent Office in March 2025. This patent relates to DNA ...

These plates are free of DNA, DNase, RNase, PCR inhibitors, ATP, and endotoxins, meaning that the risk of contamination is effectively removed and dependable PCR results are guaranteed.

This patent relates to DNA Polymerase IIIC Inhibitors, including compositions-of-matter. This is the latest in the series of granted patents and pending patent applications that Acurx has file ...

The advent of digital droplet PCR (ddPCR) has marked a paradigm shift in molecular diagnostics, offering unparalleled sensitivity, precision, and reproducibility. Within the domain of forensic science ...

Unlike qPCR, dPCR doesn’t require a standard curve, it’s more accurate when measuring very low amounts of a target, and it’s less vulnerable to PCR inhibitors that might be present in the ...

Digital PCR was therefore more sensitive and more ... With targeted therapy using tyrosine kinase inhibitors (TKIs), patients with CML may achieve deep molecular responses. Patients who reach ...

An increase in Ct values with increasing amount of template would be a clear indication of PCR inhibitors present in the sample. An increase in the PCR input volume used as a template in the ...

Additionally, the assurance that these tubes are free from PCR inhibitors, UV leachables, and human DNA further enhances the reliability of experimental outcomes by preventing any potential ...

Digital PCR was therefore more sensitive and more ... With targeted therapy using tyrosine kinase inhibitors (TKIs), patients with CML may achieve deep molecular responses. Patients who reach ...

Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. The Company's approach ...